• BV6 as a Precision IAP Antagonist: Mechanisms, Limitations,

  2026-07-02

  Explore how BV6, a potent IAP antagonist, uniquely modulates apoptosis and radiosensitization in cancer and endometriosis models. This article delivers advanced mechanistic insights, practical protocol guidance, and a critical synthesis of recent mitochondrial apoptosis research.

• Q-VD-OPh: Potent Pan-Caspase Inhibitor for Apoptosis Researc

  2026-07-02

  Q-VD-OPh is a highly selective pan-caspase inhibitor that irreversibly targets caspases central to apoptosis. It supports apoptosis research across species and enhances post-cryopreservation cell viability. This dossier details its mechanism, evidentiary benchmarks, and integration into experimental workflows.

• Primary Cilia Damage Drives Biliary Complications in Liver T

  2026-07-01

  This study uncovers how damage to primary cilia in biliary epithelial cells leads to cellular senescence and persistent biliary complications following liver transplantation. Targeted preservation or restoration of primary cilia and interventions against senescence could significantly improve graft regeneration and clinical outcomes.

• OM-MSCs Mitigate Golgi Stress via PI3K/Akt/mTOR After Stroke

  2026-07-01

  This study demonstrates that olfactory mucosa mesenchymal stem cells (OM-MSCs) alleviate Golgi apparatus stress following cerebral ischemia/reperfusion injury by activating the PEDF-PI3K/Akt/mTOR pathway. These findings clarify a novel neuroprotective mechanism and support further exploration of targeted strategies for ischemic stroke recovery.

• Optimizing Cell Assays with 5,6-Dichloro-1-β-D-ribofuranosyl

  2026-06-30

  This article addresses key challenges in cell viability and transcriptional studies, highlighting how 5,6-dichloro-1-β-D-ribofuranosyl-1H-benzimidazole (DRB, SKU C4798) provides robust, reproducible solutions. Scenario-driven Q&A blocks guide researchers in employing DRB for inhibition of RNA polymerase II, HIV transcription inhibition, and antiviral studies, with actionable protocol guidance and practical vendor advice.

• AT-406 (SM-406): Mechanistic and Strategic Leverage in Cance

  2026-06-30

  Explore how AT-406 (SM-406), a potent IAP antagonist, transforms translational cancer research by enabling precise apoptosis pathway activation and chemosensitization. This article bridges mechanistic insight with strategic experimental guidance, contextualizes AT-406’s value against competitive approaches, and provides a practical roadmap for oncology investigators.

• Distinct Apoptosis Pathways in BMECs Induced by Candida krus

  2026-06-29

  This study reveals that the yeast and hypha phases of Candida krusei trigger apoptosis in bovine mammary epithelial cells (BMECs) via separate molecular signaling routes. The findings clarify the cell death mechanisms underlying mycotic mastitis and inform targeted experimental approaches for dissecting apoptosis in veterinary and pathogen-host interaction contexts.

• MCL-1’s Canonical Anti-Apoptotic Role in Breast Cancer Unvei

  2026-06-29

  This study rigorously demonstrates that breast cancer’s dependence on MCL-1 is rooted in its traditional anti-apoptotic activity, rather than non-canonical functions. Through genetic and pharmacologic targeting in relevant models, it establishes that disrupting MCL-1’s canonical function impedes tumor progression, guiding future apoptosis-targeted therapies.

• CF10 and EdU Synergy Drives Telomere Attrition in CRC Cells

  2026-06-28

  The reference study reveals that the fluoropyrimidine polymer CF10 synergizes with 5-ethynyl-2′-deoxyuridine (EdU) to accelerate telomere attrition and induce mitotic catastrophe in colorectal cancer cells. This mechanism, distinct from traditional thymidylate synthase inhibition, highlights new opportunities for telomerase pathway disruption in precision oncology.

• (S)-Mephenytoin in Next-Generation Intestinal Organoid Assay

  2026-06-27

  (S)-Mephenytoin is a pivotal CYP2C19 substrate driving precision in cytochrome P450 metabolism studies. This article explores its advanced role in human iPSC-derived intestinal organoids, offering novel guidance for translational pharmacokinetic research and practical workflow optimization.

• PPT (Propyl Pyrazole Triol): Precision ERα Agonist in Applie

  2026-06-26

  PPT (Propyl Pyrazole Triol) delivers unmatched selectivity for ERα, enabling rigorous dissection of estrogen receptor signaling in both cancer and developmental biology. This article unpacks advanced use-cases, stepwise workflows, and expert troubleshooting, translating recent biomarker network discoveries into actionable protocol enhancements.

• OM-MSCs Mitigate Golgi Stress via PEDF-PI3K/Akt/mTOR in Stro

  2026-06-26

  This study demonstrates that olfactory mucosa mesenchymal stem cells (OM-MSCs) alleviate Golgi apparatus stress after cerebral ischemia/reperfusion injury by activating the PEDF-PI3K/Akt/mTOR pathway. These findings clarify a novel neuroprotective mechanism and suggest actionable targets for experimental stroke therapies.

• MLN8237 (Alisertib): Applied Workflows for Cancer Biology Re

  2026-06-25

  MLN8237 (Alisertib) offers unmatched specificity for Aurora A kinase, unlocking new avenues in apoptosis induction, tumor growth suppression, and immune epigenetics. This article translates recent mechanistic insights and validated protocols into optimized experimental workflows, helping researchers maximize reproducibility and biological impact.

• ERAD-Hijacking Chimeras Enable Degradation of TM Proteins

  2026-06-25

  Song et al. present ERAD-engaging chimeras (ERADECs), a new small-molecule platform that hijacks the endoplasmic reticulum-associated degradation (ERAD) pathway to selectively degrade transmembrane proteins. This strategy addresses longstanding barriers in targeted protein degradation and offers new opportunities for membrane protein and immunology research.

• Calpeptin: Calpain Inhibitor Protocols in Pulmonary Fibrosis

  2026-06-24

  Calpeptin enables researchers to dissect calpain-driven pathways in fibrosis and inflammation with nanomolar precision. This guide translates cutting-edge reference data and peer-reviewed workflows into actionable protocols, troubleshooting, and optimization strategies for fibrosis research.

16735 records 1/1116 page Next 12345 下5页 Last page